Načítá se...
Conditional approval of cancer drugs in Canada: accountability and impact on public funding
BACKGROUND: We examined how conditional market approval of cancer pharmaceuticals by Health Canada (hc) affects public funding recommendations by the pan-Canadian Oncology Review (pcodr). We were also interested to see how often hc conditions are enforced. METHODS: Health Canada and pcodr databases...
Uloženo v:
| Vydáno v: | Curr Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Multimed Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380633/ https://ncbi.nlm.nih.gov/pubmed/30853815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4397 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|